Striopallidodentate calcinosis
Striopallidodentate (SPD) calcinosis, a condition first described in 1930 by T. Fahr and therefore called Fahr syndrome, is a genetic (inherited) neurological disorder characterized by abnormal deposits of calcium in certain of areas of the brain (including the basal ganglia and the cerebral cortex).
Symptoms may include motor function deterioration, dementia, mental retardation, spastic paralysis, dysarthria (poorly articulated speech), spasticity (stiffness of the limbs), ocular (eye) problems, and athetosis (involuntary, writhing movements).
Features of Parkinson’s disease such as tremors, rigidity (resistance to imposed movement), a mask-like facial appearance, shuffling gait, and a “pill-rolling” motion of the fingers may also occur in individuals with Fahr’s syndrome. Other symptoms may include dystonia (disordered muscle tone), chorea (involuntary, rapid, jerky movements), and seizures. Onset of the disorder may occur at any time from childhood to adulthood.
Fahr syndrome thus involves abnormalities of the neurologic system (cerebral calcification, dementia, spastic paraplegia, athetosis), skull (microcephaly, i.e. an abnormally small head), eyes (glaucoma, optic nerve atrophy, retinitis pigmentosa), and, we would add, a significant hormone problem, namely hypoparathyroidism (the parathyroid gland regulates calcium).
The disease is inherited as an autosomal recessive trait in which both parents carry a Fahr gene and each of their children (boys and girls alike) stands a 1 on 4 (25%) risk of receiving both Fahr genes and therefore having this dread disease.
There is no cure for Fahr’s syndrome, nor is there a standard course of treatment. Treatment is directed toward minimizing symptoms.
The prognosis (outlook) for individuals with Fahr’s syndrome is poor. Progressive neurological deterioration generally results in disability and death.
Alternative names for this syndrome include striopallidodentate calcinosis and cerebrovascular ferrocalcinosis.
Read Also:
- Stripping
Surgery to treat varicose veins. The problematic veins are “stripped” out by passing a flexible device through the vein and removing it through an incision near the groin. Smaller tributaries of these veins also are stripped with this device or removed through a series of small incisions. Those veins that connect to the deeper veins […]
- Stroke
The sudden death of brain cells due to lack of oxygen, caused by blockage of blood flow or rupture of an artery to the brain. Sudden loss of speech, weakness, or paralysis of one side of the body can be symptoms. A suspected stroke can be confirmed by scanning the brain with special X-ray tests, […]
- Stroke index
A cardiodynamic measure. Stroke volume is the amount of blood the left ventricle ejects in one beat, measured in milliliters per beat (ml/beat). The stroke volume can be indexed to a patient’s body size by dividing by the body surface area to yield the stroke index.
- Stroke volume
The amount of blood pumped by the left ventricle of the heart in one contraction. The stroke volume is not all the blood contained in the left ventricle; normally, only about two-thirds of the blood in the ventricle is expelled with each beat. Together with the heart rate, the stroke volume determines the output of […]
- Stroke, National Institute Neurological Disorders
One of the National Institutes of Health in the U.S., the NINDS’s mission is to “support and conduct research and research training on the normal structure and function of the nervous system and on the causes, prevention, diagnosis, and treatment of more than 600 nervous system disorders including stroke, epilepsy, multiple sclerosis, Parkinson’s disease, head […]